Venture Capital

Benesch represents sponsors of venture capital funds in their capital raising and investing activities as well as emerging growth companies seeking venture capital financing. We represent sophisticated institutional investors in funds and our lawyers are knowledgeable about market terms and trends. Additionally, we provide advice in connection with transfers of limited partner interests, distributions in kind, general partner management changes, dissolution and liquidation mechanics.

emailpdflinkedin

Overview

Between the number of private equity and venture capital financings we close each year and our familiarity with emerging trends in the industry, Benesch is able to assist our clients in offering and obtaining current, competitive financing terms. From the structuring of bridge loans through the sophisticated negotiation of later-stage financings, our lawyers provide advice that positions clients to close transactions swiftly and efficiently. Our private equity and venture capital lawyers assist clients in their due diligence review of corporate, patent and other intellectual property and other issues in connection with potential investments.

We represent a number of venture capital-backed portfolio companies in the health care, biotechnology and life sciences area.

Related Practices

Corporate

Our Work in Action

Representative Examples

Representation of a medical diagnostics company

as corporate counsel in multiple rounds of venture investing and the sale to a strategic independent service provider for medical equipment.

Representation of a nanotechnology licensing

company in four rounds of financing which amounted to approximately $43 million.

Representation of a venture backed company

developing technologies that include life science applications, raising through bridge and multiple venture rounds in excess of $20 million.

Representation of a portfolio company of Cleveland Clinic Innovations

in the cancer testing/screening industry in connection with a significant venture capital investment by a major Israeli venture capital fund.

Representation of related businesses in new energy and energy conversion technologies

in connection with in excess of $25 million of capital raises, licensing, IP portfolio development and spin out transactions.

Representation of an early stage cloud-based health IT company

in connection with a $25 million private placement with a major national venture capital fund.

Representation of a nutraceutical business in connection with capital raises

amounting to in excess of $20 million through multiple rounds of venture equity and structured long term debt, as well as its operating concerns and licensing business.

High performance in practice

Recognized by Chambers® 2025

Ranked Nationally

in Corporate Law, Securities / Capital Markets Law, and Securities Regulation – 2026 Best Lawyers® “Best Law Firms”

Named a Standout in M&A

BTI Consulting Group

Award-Winning Leadership

including recognitions from The Deal, ACG, Global M&A Network and more

Experience

Regularly counsels start-ups and early stage businesses in the consumer products and technology industries in connection with early stage equity and debt financings.

Key Contacts: Megan Ratia

Represented Aglaé Ventures – a technology focused investment firm backed by Agache (formerly Groupe Arnault) – in connection with early stage and growth equity tech and Web3 investments, including over 50 distinct investments.* ​

Key Contacts: Megan Ratia

Represents EIGHT – an elite light lager brand co-founded by Troy Aikman – in connection with its Series Seed financing, commercial partnerships and governance arrangements.*

Key Contacts: Megan Ratia

Represents L Catterton – the largest global consumer-focused private equity firm – in growth equity and early-stage investments, including over 20 distinct investments to date.*

Key Contacts: Megan Ratia

Represented Kaden Health, an online addiction treatment and behavioral health company, in its corporate governance and capital raising initiatives.

Key Contacts: Jennifer L. Stapleton

Represented J. Pritchard, a premium apparel line for pickleball, in its strategic growth initiatives.

Key Contacts: Jennifer L. Stapleton

Represented ATUM in its strategic corporate venture investment initiatives.

Key Contacts: Jennifer L. Stapleton

Represented AppHarvest in its strategic corporate venture investment initiatives.

Key Contacts: Jennifer L. Stapleton

Represented Mednition Inc., a provider of AI-powered risk intelligence software to hospital systems, in its Series A financings.

Key Contacts: Jennifer L. Stapleton

Represented LAND Energy, Inc. in its Series A financings.

Key Contacts: Jennifer L. Stapleton

Represented Amprion, a developer of technology for the early detection of neurodegenerative brain diseases in connection with offering of Series A Preferred Stock.

Key Contacts: Jennifer L. StapletonIra C. KaplanAllan GoldnerBrian D. Mielcusny

No results found